This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Mental health treatments face higher regulatory hurdles for approval, warns Impe...
UK drugmaker says Emma Walmsley is underpaid compared with global competitors
Pharmaceutical industry is hoping to ward off growing tariff threat
Advanced early warning systems boost ability to flag higher likelihood of health...
Generic drugmaker Stada is preparing for what could be Europe’s biggest IPO this...
US hedge fund shorts drugmaker as shares trade below price of a decade ago
Advisory group was set to weigh in on nearly a dozen jabs in a meeting later thi...
Local pharma groups have taken over a lucrative niche market
Lawsuit claims UK pharma giant understated the risk of government investigations
Exploring how a social enterprise can balance pharmaceutical sales targets with ...
BioArctic is developing a process to allow drugs to cross the layer of cells tha...
Hedge fund’s short position is the biggest in the FTSE 100 group in more than a ...
Research highlights growing focus on surrounding tissues to help tackle most mal...
Research highlights growing focus on surrounding tissues to help tackle most mal...
Simon Kohl aims to capitalise on his experience with Nobel Prize-winning AlphaFo...
Simon Kohl aims to capitalise on his experience with Nobel Prize-winning AlphaFo...
Farallon presses Astellas to cut costs and overhaul drugs research in latest sha...
Healthcare company is trying to reorganise and rebuild its medical technology di...
Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abe...
A battle over how to treat childhood obesity is brewing between those in favour ...
US president says Ross Ulbricht was victim of ‘weaponisation of government’
Nominee says he is entitled to 10% of proceeds if case against Merck’s Gardasil ...
Sector knocked by disappointing sales, an unexpected trial result and questions ...